Clinical Trials

Esophageal Squamous Cell Carcinoma

NCT06013618 2025-06-17

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Phase 2 Recruiting

120 enrolled

CNS

Neuroblastoma

NCT07018427 2025-06-12

Real-world Study of Sacituzumab Govitecan Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Active not recruiting

70 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06993506 2025-05-29

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Not yet recruiting

500 enrolled

Neoplasm Metastasis, Recurrence

NCT06967233 2025-05-13

Multimodal Managements for Metastatic Pancreatic Cancer.

Completed

360 enrolled

Pancreatic Neoplasms

NCT06793306 2025-02-14

A Study Comparing the Differences Between Young and Non-young Breast Cancer

Enrolling by invitation

3,000 enrolled

Breast Neoplasms

NCT03978481 2024-11-29

Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study

Completed

3,700 enrolled

Stomach Neoplasms

NCT03034473 2023-12-28

TransValid-A

Phase NA Unknown

200 enrolled

Locally Advanced Rectal Cancer

NCT05228951 2022-09-13

Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC

Phase 2 Recruiting

12 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT04486911 2022-08-02

Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial

89 enrolled

Breast Neoplasms

NCT05174156 2022-07-14

Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer

50 enrolled

Advanced Esophageal Cancer

NCT05206890 2022-01-26

A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer

Recruiting

490 enrolled

Gynecologic

Ovarian Neoplasms

NCT04718701 2021-08-16

ATNPA

53 enrolled

Pancreatic Neoplasms

NCT04846452 2021-08-12

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

40 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04413734 2020-06-04

Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

120 enrolled

Cholangiocarcinoma

NCT04161794 2019-11-13

Multimodal Intervention for Patients With Non-small Cell Lung Cancer

58 enrolled

Cachexia, Neoplasms

NCT03580980 2018-07-10

Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries

90 enrolled

Neoplasms, Pain, Postoperative

NCT02427399 2017-06-22

Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients

1,100 enrolled 8 charts

Gynecologic

Uterine Cervical Neoplasms

NCT01769508 2016-06-13

Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer

Phase 2 Terminated

12 enrolled 8 charts

HER2 Positive Esophagogastric Cancer

NCT01889420 2015-07-31

Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Phase 1 Terminated

1 enrolled 3 charts

Plasma cell

Recurrence, Neoplasms, Plasma Cell

NCT01226719 2015-05-27

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Phase 2 Completed

15 enrolled 7 charts

Colorectal Neoplasms

NCT02165696 2014-06-17

LYMPHATIC

Phase NA Unknown

44 enrolled

GastrointestinalGynecologic

Breast Neoplasms, Lymphedema

NCT01379482 2014-05-06

Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer

Phase 2 Completed

18 enrolled

Peritoneal Neoplasms, Stomach Neoplasms

NCT01566994 2013-09-17

Comparing Population Cessation Services